(Q35219754)

7 August 2017

1 reference

title

Elevated plasma homocysteine as risk factor for peripheral arterial disease--what is the evidence? (English)

1 reference

7 August 2017

Lloyd M Taylor

1

1 reference

7 August 2017

publication date

1 September 2003

1 reference

Seminars in Vascular Surgery

7 August 2017

published in

1 reference

7 August 2017

volume

16

1 reference

7 August 2017

issue

3

1 reference

7 August 2017

page(s)

215-222

1 reference

The ankle-brachial index as a predictor of survival in patients with peripheral vascular disease

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

HOMOCYSTINURIA: AN ENZYMATIC DEFECT.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Homocystinuria associated with decreased methylenetetrahydrofolate reductase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Homocystinemia. Vascular injury and arterial thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Homocysteine and lipid metabolism in atherogenesis: effect of the homocysteine thiolactonyl derivatives, thioretinaco and thioretinamide

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Modulation of transforming growth factor-beta 1 antiproliferative effects on endothelial cells by cysteine, cystine, and N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Homocysteine increases cyclin-dependent kinase in aortic rat tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

The pathogenesis of coronary artery disease. A possible role for methionine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Cysteine—Homocysteine Mixed Disulphide: Differing Plasma Concentrations in Normal Men and Women

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Protein-Bound Homocyst(e)ine in Normal Subjects and in Patients with Homocystinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Higher Plasma Homocyst(e)ine and Increased Susceptibility to Adverse Effects of Low Folate in Early Familial Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Plasma homocyst(e)ine levels and graded risk for myocardial infarction: findings in two populations at contrasting risk for coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Impaired homocysteine metabolism: a risk factor in young adults with atherosclerotic arterial occlusive disease of the leg

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Prevalence of familial hyperhomocyst(e)inemia in men with premature coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction. A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Methylenetetrahydrofolate reductase gene and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Serum total homocysteine and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

A prospective study of plasma homocyst(e)ine and risk of ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Plasma homocysteine levels and mortality in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Reduction of plasma lipid and homocysteine levels by pyridoxine, folate, cobalamin, choline, riboflavin, and troxerutin in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Homocysteine in the plasma of renal transplant recipients: effects of cofactors for methionine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: possible implications for prevention of vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Vascular disease and homocysteine metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Decreased rate of coronary restenosis after lowering of plasma homocysteine levels

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

The effect of folic acid fortification on plasma folate and total homocysteine concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

Homocysteine and myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7967%2803%2900027-9

7 January 2021

10.1016/S0895-7967(03)00027-9

Identifiers

DOI

1 reference

7 August 2017

1 reference